Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Redman

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
JAMA|April 21, 1993
Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspringJ B Redman, R G Fenwick, Y H Fu, et al.
Journal of the American Academy of Dermatology|April 25, 2000
Management of melanoma with a multidisciplinary melanoma clinic modelT M Johnson, A Chang, B Redman, et al.
Breast Cancer Research and Treatment|December 1, 1990
Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancerS Martino, B A Samal, B Redman, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Apparent homozygosity of a novel frame shift mutation in the CFTR gene because of a large deletionFeras M Hantash, Arlene Rebuyon, Mei Peng, et al.
Cancer|August 5, 2000
Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinomaC Trivedi, B Redman, L E Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostateK J Pienta, B Redman, M Hussain, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 10, 2004
Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratoryCharles M Strom, Beryl Crossley, Joy B Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanomaM B Atkins, B Redman, J Mier, et al.
Leukemia Research|September 1, 1995
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphomaR M Mohammad, H Diwakaran, A Maki, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 10, 2004
Cystic fibrosis screening: lessons learned from the first 320,000 patientsCharles M Strom, Beryl Crossley, Joy B Redman, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
JAMA|April 21, 1993
Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspringJ B Redman, R G Fenwick, Y H Fu, et al.
Journal of the American Academy of Dermatology|April 25, 2000
Management of melanoma with a multidisciplinary melanoma clinic modelT M Johnson, A Chang, B Redman, et al.
Breast Cancer Research and Treatment|December 1, 1990
Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancerS Martino, B A Samal, B Redman, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Apparent homozygosity of a novel frame shift mutation in the CFTR gene because of a large deletionFeras M Hantash, Arlene Rebuyon, Mei Peng, et al.
Cancer|August 5, 2000
Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinomaC Trivedi, B Redman, L E Flaherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostateK J Pienta, B Redman, M Hussain, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 10, 2004
Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratoryCharles M Strom, Beryl Crossley, Joy B Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanomaM B Atkins, B Redman, J Mier, et al.
Leukemia Research|September 1, 1995
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphomaR M Mohammad, H Diwakaran, A Maki, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 10, 2004
Cystic fibrosis screening: lessons learned from the first 320,000 patientsCharles M Strom, Beryl Crossley, Joy B Redman, et al.
Pageof 5